We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Culture Detection Times Distinguishes Bacteremia from Contamination

By LabMedica International staff writers
Posted on 27 Dec 2015
Contamination of blood culture is common, very costly for the health system, and often confuses clinicians. More...
To minimize the risk of blood culture contamination with the normal skin flora, meticulous attention should be paid when preparing the skin for venipuncture.

Clinicians should be notified every time there is a positive blood culture because the microorganism can often represent an infection that may lead to death and moreover, knowledge of the start times for adequate antibiotic therapy is critical for the prognosis of patients with sepsis and bacteremia.

Scientists at the Fuenlabrada University Hospital (Madrid, Spain) conducted a retrospective study of a database of 1,334 patients with a positive blood culture between January 2011 and June 2013. Together with the final blood culture results and the patient's history, growth was then analyzed to assess whether it represented true bacteremia or bacterial contamination. The earliest detection times of bacterial growth in each batch of blood cultures were analyzed in a blinded fashion after classification.

The BacT/Alert blood culture system (BioMérieux; Marcy l'Etoile, France) was employed throughout the study. Two pairs of blood culture vials were used for each patient, with a total recommended extracted volume of blood of 20 mL to 40 mL. These four vials, two for aerobic and two for anaerobic culture, were termed a “blood culture batch.” Blood cultures were performed depending on medical criteria in patients with suspected sepsis as there is no predictive model able to identify which patients should have blood cultures done.

In total, 590 batches of blood cultures corresponded to true bacteremia and 744 to bacterial contamination. In the bacteremia group, the median growth time was 12.72 hours. In the contaminated blood culture group, the median growth time was 20.6 hours which was statistically highly significant. Microorganisms such as Candida species and Bacteroides species presented median growth times significantly longer than those of the other microorganisms. The administration of antibiotics in the week prior to bacteremia was found to delay the growth time of microorganisms.

The authors concluded that the time at which growth is detected in blood cultures using the automated BacT/Alert system could inform clinicians of whether the culture represents true bacteremia or not, pending the time required for a definitive identification of the microorganism involved. The factors that influence these growth times are the association of the culture with true bacteremia, the prior use of antibiotic therapy, and the type of microorganism. The study was published in the December 2015 issue of the International Journal of Infectious Diseases.

Related Links:

Fuenlabrada University Hospital 
BioMérieux 



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.